Z-0494-2025 Class II Ongoing

Recalled by Abbott Medical — Saint Paul, MN

FDA device recall Z-0494-2025 was initiated by Abbott Medical on Oct 17, 2024 and is designated Class II. Reason for recall: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the… The recall status is ongoing. Affected quantity: 8 OUS.

Recall details

Product Type
Devices
Report Date
Nov 27, 2024
Initiation Date
Oct 17, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8 OUS

Product description

Abbott Navitor, Vision Technology, Transcatheter Aortic Heart Valve, 27 mm, NVRO-27, Sterile

Reason for recall

A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.

Distribution pattern

New York, Australia, Belgium, Germany, Iran, Israel, Japan, Kazakhstan, Oman, Poland, Romania, Slovakia, Spain, Turkey, United Kingdom.

Code information

UDI-DI (GTIN): 5415067045799, Serial Numbers: 20158135, 20172203, 20183968, 20184552, 20184670, 20184675, 20190249, & 20213055.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0494-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0494-2025. Report a data issue: hello@regdatalab.com.